Donation from uncontrolled circulatory determination of death donors (uDCD) is impractical in United States because of the time needed to organize procurement before irreversible organ damage. Salvaging organs after prolonged warm ischemic time (WIT) may address this limitation. We evaluated the combination of extracorporeal support (ECS) and thrombolytics in a porcine uDCD renal transplant model. Nonanticoagulated uDCD sustained 60 min of WIT, and two groups were studied. Rapid recovery (RR)-uDCD renal grafts procured using the standard quick topical cooling and renal flush, and ECS-assisted donation (E-uDCD), 4 hr ECS plus thrombolytics for in situ perfusion before procurement. All kidneys were flushed and cold stored, followed by transplantation into healthy nephrectomized recipients without immunosuppression. Delayed graft function (DGF) was defined as creatinine more than 5.0 mg/dl on any postoperative day. Twelve kidneys in E-uDCD and 6 in RR-uDCD group were transplanted. All 12 E-uDCD recipients had urine production and adequate function in the first 48 hr, but two grafts (16.7%) had DGF at 96 hr. All six recipients from RR-uDCD group had DGF at 48 hr and were killed. Creatinine and blood urea nitrogen (BUN) levels were significantly lower in E-uDCD compared with RR-uDCD group at 24 hr (2.9 ± 0.7 mg/dl vs. 5.2 ± 0.9 mg/ dl) and 48 hr (3.2 ± 0.9 mg/dl vs. 7.2 ± 1.0 mg/dl); BUN levels at 24 and 48 hr were 28.3 ± 6.7 mg/dl vs. 39.5 ± 7.5 mg/dl and 23.9 ± 5.0 mg/dl vs. 46 ± 12.9 mg/dl, respectively. Thrombolytics plus ECS precondition organs in situ yielding functional kidneys in a porcine model of uDCD with 60 min of WIT. This procurement method addresses logistical limitations for uDCD use in the United States and could have a major impact on the organ donor pool. ASAIO Journal 2015; 61:474-479.
Organ donation after circulatory determination of cardiac death (DCD) could be a major source of organs for transplantation. However, DCD is limited by the logistics of procuring organs immediately after death. Organs deteriorate quickly during the warm ischemic time (WIT) between withdrawal of care, determination of death, and organ retrieval. In some decorticate (but not brain dead) patients, supportive care is electively withdrawn, the heart stops, and organs can be taken urgently after the heart stops (controlled DCD [cDCD]), but the logistics are so difficult that cDCD accounts for less than 8% of all deceased donors in the United States. 1, 2 The logistical problems and the WIT can be minimized in cDCD by in situ perfusion of warm oxygenated blood using extracorporeal support (ECS) that allows reperfusion, conditioning, and evaluation of organs before elective removal; this is called extracorporeal support-assisted circulatory determination of death donor (E-DCD).
We have reported the largest series of E-DCD. 3, 4 This experience addressed many of the logistical problems resulting in elective organ retrieval and successful transplantation of kidneys, livers, and pancreas.
Routinely E-DCD results in successful transplantation, but the number of potential donors is relatively small. A much larger source of DCD organs could be death after unexpected cardiac arrest (uncontrolled circulatory determination of death donor [uDCD] ), but the logistics of establishing ECS within few minutes after death make E-DCD in unexpected, uncontrolled death difficult, if not impractical.
In an animal model, we have studied the details of temperature, anticoagulation, pressure, flow, adjuvant medication, and WIT. [5] [6] [7] [8] Our results had shown that room temperature ECS is as effective as 37°C and that ECS can be used during DCD donation in animals anticoagulated with heparin before or soon after cardiac arrest. This results in conditioning of kidneys, livers, and lungs to transplantable status after 30 min of WIT. However, in these experiments, kidneys routinely presented poor urine output and low creatinine clearance after 30 min WIT, despite full premortem heparinization of the donor when the "rapid recovery (RR)" technique was used. Renal grafts were in successful condition and functional if ECS in situ perfusion was used. In these experiments, we found that microvascular thrombosis during WIT caused kidney failure uniformly. 5 Intravascular thrombosis after death seems to limit tolerable WIT longer than 30 min, even with ECS and heparinization. This study was undertaken to evaluate the use of ECS with streptokinase (STK) as a thrombolytic, on kidney resuscitation and transplantation after 60 min of untreated WIT after cardiac death.
Methods

Animals and Anesthesia
All animals were cared for by the standards of the University Committee on Use and Care of Animals (UCUCA) at the University of michigan. Pigs with a weight of 25-30 kg were used. Animals were anesthetized, and hemodynamic monitoring lines were placed as previously described. 5 Porcine model of uDCD. An uDCD model of organ donation with 1 hr of WIT was used for donor animals. After placement of catheters for hemodynamic monitoring, the left femoral artery (14-16 fr) and vein (18-20 fr) were dissected and prepared for cannulation. next, a left-side thoracotomy was performed from cephalic to the diaphragm, and an umbilical tape was passed around the descending aorta immediately proximal to the diaphragmatic hiatus. Cardiac arrest was induced by apnea via ventilator withdrawal, and paralytics were given as previously described. 5, 7 no heparin was given before cardiac arrest, and no external heat source was used, to mimic a clinical uDCD setting. Circulatory death was defined as a systolic carotid arterial pressure less than 20 mm Hg and a pulse pressure less than 10 mm Hg. The agonal period, defined as the time between vent withdrawal and circulatory arrest, was measured. The protocol is shown in Figure 1 .
ECS circuit. The Automated Perfusion System (APS; mC3, Ann Arbor, michigan) is a prototype ECS circuit designed specifically for E-uDCD. The circuit consists of a peristaltic pump (m-pump), with compliant pump chamber, which allows for Starling flow pump behavior and prevents cavitation, and a membrane oxygenator (mC3 biolung). 9, 10 The APS prime included the following: 100 mEq sodium bicarbonate, 0.5 g methylprednisolone, 12.5 g mannitol, 10,000 units heparin, and 1 mIU STK. The priming volume was approximately 400 ml. Another 1 mIU STK was diluted in 500 ml of normal saline solution and given slowly throughout the perfusion.
Experimental group (uncontrolled ECS-assisted uDCD)-E-uDCD group. After the agonal period and circulatory arrest without premortem anticoagulation, no intervention was made for 60 min in the donors (n = 6 donors, n = 12 kidneys). After 60 min of arrest, venoarterial perfusion was initiated via the femoral vessels. The distal thoracic aorta was occluded to simulate the occluding of intravascular aortic balloon used in the clinical protocols. The ECS-assisted donation was performed for 4 hr at room temperature (28 ± 2°C). Systemic arterial, device inlet, and device outlet blood gases were measured every 15-30 min to monitor physiologic changes during ECS. During the ECS run, target mean device outlet pressures and circuit flows were 65-75 mm Hg and more than 50 ml/kg/min, respectively. Intravenous fluids were administered as indicated for low pump filling pressures, and device flow was adjusted to meet the targets.
Kidney procurement. After 4 hr of ECS, a midline laparotomy was performed, and both kidneys were procured without interruption of perfusion. both kidneys were then flushed with 120-150 ml of cold Custodiol-HTK Solution (Essential Pharmaceuticals llC, Ewing, nJ). One kidney was transplanted directly (simulating living donor procurement). The other kidney was stored at 5°C in an iced-cooler (simulating standard cold storage). The stored kidney was transplanted into a different recipient after 4 hr.
Control group (uncontrolled rapid recovery DCD) rapid recovery model. Kidneys were retrieved from similar uDCD subjects after 60 min of WIT, without premortem anticoagulation. Donor animals (n = 3 donors, n = 6 kidneys) were anesthetized, instrumented, and killed as described earlier. A midline incision was made, and the kidneys immediately procured for transplant without ECS or thrombolytics. After flushing with 120-150 ml of cold HTK, one kidney was immediately transplanted and the other cold stored before transplant, as the experimental group. This control group simulates the technique of "RR". Clinically RR is used only when the WIT is less than 10 min; hence, this model is well outside the range when RR would be used usually. On the basis of our previous experience, we expected no renal function in the control group, so we limited the number of donors to three.
Renal Transplantation Model (Nephrectomized Healthy Swine)
After carotid arterial and jugular venous catheters were placed and tunneled for chronic access in recipient animals, a midline laparotomy was performed, and both kidneys were nephrectomized before transplant. The distal aorta and inferior vena cava were dissected and prepared for anastomosis. Sodium heparin of 150 units/kg was given before vessel clamping. Renal venous and arterial anastomoses were then completed, and a ureteral stent was placed across the bladder anastomosis. methylprednisolone of 250 mg was given before reperfusion of the kidney. no additional immunosuppression was given to recipient animals. Urine output at the time of ureteral anastomosis was recorded. In this model, rejection does not occur until 7 days, 11 so normal renal function should occur immediately after transplant and continue for 4 days.
Postoperative care. Recipient animals were allowed to recover after surgery and to eat and drink freely. Intravenous fluid administration, medication administration, and blood draws were performed according to the schedule shown in Table 1 . blood was drawn daily for measurements of urea and creatinine. no immunosuppression was given to minimize any discussion about medications that may affect or improve immediate renal function. It has been described that porcine kidney allografts present with uniform rejection after 7 days without immunosuppression. 11 Renal failure was defined as creatinine more than 5 mg/dl for two consecutive days. Animals with renal failure were terminated. Animals with functioning grafts were terminated for evaluation at 2, 3, and 4 days posttransplant. Animals were euthanized with 7 ml of fatal-Plus solution (vortech Pharmaceuticals ltd., Dearborn, mI); necropsy was performed; and kidneys were removed for histology.
Histology. Kidney damage was assessed on hematoxylin and eosin-stained slides by an experienced and blinded veterinary pathologist. The extent of proximal tubule necrosis, degeneration, and regeneration was scored from 0 (normal) to 3 (severe). Tubulointerstitial inflammation, interstitial fibrosis, and perivascular lymphoplasmocytic infiltration were also scored from 0 to 3 by the same criteria. Each slide was scored blindly on two consecutive days, and rare differences were resolved by a third evaluation.
Data Analysis
Independent sample Student's t-tests were performed to determine significant differences in postoperative serum creatinine and blood urea nitrogen (bUn) levels between experimental group (E-uDCD) and control group (RR-uDCD) animals. All analyses were performed using SPSS predictive analytic software (International business machines Corp., Armonk, ny). A p < 0.05 was considered statistically significant.
Results
Six donor animals were used for E-uDCD, which resulted in 12 transplanted kidneys in this group. Three donor animals were used for six control kidneys, RR-uDCD. for all donors, mean agonal time was 15.8 ± 0.8 min, and mean WIT was 64.4 ± 1.0 min (death to ECS or to rapid organ procurement).
During ECS, pH and partial pressure of carbon dioxide (pCO 2 ) reached target values within 15 min in all donors. During the 4 hr perfusion period, urine output increased from 1.3 ± 0.6 ml/h to 4.2 ± 1.3ml/h. lactate levels decreased slightly through the ECS run from 10.4 to 7.7 mg/dl. measurements during perfusion are shown in Table 2 .
Hemorrhagic complications during E-uDCD were as follows: no major events were observed in this study. Initial and prior ECS hemoglobin level was 10 ± 1.9 g/dl, and at the end of 4 hr of ECS, hemoglobin level decreased to 5.5 ± 0.9 g/dl because of fluid resuscitation. However, in two animals, hemoglobin level decreased to less than 5.0 g/d, and excessive bleeding from surgical sites was observed.
All kidneys were successfully transplanted into healthy, nephrectomized recipients. mean anastomotic times for the renal vein and renal artery were 14.4 ± 1.2 min vs. 14.0 ± 1.9 min and 15.3 ± 1.3 min vs. 14.9 ± 3.6min for the E-uDCD and the RR-uDCD groups, respectively. All kidneys in the E-uDCD group made urine after vascular anastomosis. none of the control kidneys made urine during the retrieval or the transplant operation.
Postoperative Transplant Results
Initially, all 12 E-uDCD recipient animals had adequate renal function. On postoperative day 3, two animals were killed (because of an increase in serum creatinine level, meeting criteria of renal failure); both organs came from the same donor. This E-uDCD donor had lower perfusion flows (<50 ml/kg/min) and pressures (<60 mm Hg) than the target parameters set for E-uDCD. In addition, we had two complications associated with the management of the chronic arterial line (nonrenal complications) that required the killing of two animals in this group, specifically on postoperative days 3 (arterial line bleeding) and 4 (arterial line air embolism). All six RR-uDCD control kidneys met renal failure criteria on postoperative day 2 and were killed. There was no urine in the bladder. In all transplanted kidneys, vascular anastomoses were patent. Kidneys were removed for histologic examination. Creatinine levels were significantly different between groups on postoperative day 1, 2.7 ± 0.6 mg/dl compared with 5.22 ± 0.9 mg/dl (p = 5.5 × 10 −6 ), and on postoperative day 2, 3.2 ± 0.9 mg/dl compared with 7.21 ± 1.0 mg/dl (p = 1.6 × 10−6), in the E-uDCD group and the RR-uDCD control group, respectively (Figure 2) .
Similar results were observed with bUn between groups on postoperative day 1, 28.3 ± 6.7 mg/dl compared with 39.5 ± 7.1 mg/ dl (p = 0.0098), and on postoperative day 2, 23.9 ± 5.0 mg/dl compared with 46 ± 12.9 mg/dl (p = 0.0003), in the E-uDCD group and the RR-uDCD control group, respectively (Figure 3) .
Renal Pathology
Control kidneys were removed after meeting the criteria for renal failure on day 2 (Figure 4) . Histology of the control grafts showed moderate to severe multifocal extensive acute tubular necrosis, tubular proteinosis, and moderate subacute interstitial nephritis. The E-uDCD kidneys were removed on days 2, 3, and 4. The histology on day 4 showed normal blood vessels and glomeruli with mild nephrosis and interstitial nephritis. In both groups, the lesions reported by the pathologist were reversible. no difference was observed in the level of perivascular lymphocytes, tubulointerstitial nephritis, and the regeneration of proximal tubules for the E-uDCD (1.32 ± 0.2, 1.39 ± 0.2, and 0.64 ± 0.1) and the RR-uDCD (1.13 ± 0.4, 1.63 ± 0.1, and 0.50 ± 0.3) groups, respectively. However, proximal tubules necrosis was significantly higher in the RR-uDCD group (1.50 ± 0.6) compared with E-uDCD group (0.18 ± 0.1; p = 0.0042). Proximal tubule degeneration was also significantly higher in the RR-uDCD group (2.13 ± 0.4) compared with the E-uDCD group (0.86 ± 0.2; p = 0.012; Figure 4 ).
Discussion
The United network of Organ Sharing has reported that more than 108,000 candidates are awaiting a kidney as of June 2014. 1 The shortage is compounded by a plateau in the number of living donors and a decrease in the number of donors after neurologic determination of death as preventive measures decrease the severity of neurologic injury. In 2007, the Joint Commission, based on the recommendations from the Institute of medicine, mandated the use of DCD organs at all U.S. transplant centers as a means for increasing the organ supply; however, currently, DCDs comprise less than 8% of all donors. 1,2 These DCDs are almost only controlled (maastricht types III and Iv) in hospitalized patients in whom death is expected and preparations can be made for organ procurement in advance. most of the cDCD organs are recovered using the "RR" technique in which kidneys are removed within a few minutes of cardiac arrest, making application to uncontrolled arrested donors impractical.
However, by a conservative estimate, the inclusion of uDCDprimarily out of hospital cardiac arrests-could increase the number of donors by 22,000 each year, resulting in up to 44,000 additional kidney transplants if this potential is fully realized. 2 Urgently removing organs within a few minutes of death (RR technique) is impractical in the emergency room setting. However, ECS has been successful in salvaging kidneys in E-uDCD.
E-uDCD has been used clinically in Spain because of state policy on intervention after death. In Spain, DCD donation follows an "opt-out" organ donation system where consent for donation is implied unless otherwise specified. 12 With an ECS machine primed and available, cannulation and ECS can be instituted by ER staff within 5 min of patient arrival. With warm ECS underway, there is ample time to contact the transplant team and family. The results of successful transplantation are very good in witnessed arrest because the WIT is known and short. The results of ECS with out-of hospital arrest of longer or unknown WIT are still acceptable, because the function of perfused kidneys can be measured, and only functional kidneys are taken for transplantation. [13] [14] [15] This approach requires cannulation and management of the ECS system by trained emergency room staff. It has rarely been reported in the United States, primarily because of policies that require family consent before any interventions are instituted on dead body (the opt-in donation system). Until and unless the United States adopt a opt-out policy, the use of uDCD donors depends on extending the tolerable WIT, preferably to at least 1 hr.
However, even in Spain, cannulation and perfusion must be initiated within a few minutes of death. If kidneys could be procured after an hour or more of WIT, the limitations of uDCD could be solved. In this animal model of uDCD, we demonstrated that the combination of ECS and thrombolytics can result in routinely functional kidneys after 60 min of WIT. from our experience, we knew that the controls would routinely fail, which is why we conducted only six controls. It is possible that some might have recovered function after a period on dialysis, but our experiment was designed to evaluate immediate renal function. We also knew that ECS alone would not restore kidney function after 60 min of WIT. However, we found that ECS plus thrombolytics was routinely successful.
Several groups have studied prolonged WIT (>45 min) in porcine and canine models of renal transplantation. brasile et al. have studied prolonged WIT (2 hr) in a canine autotransplant model after ex situ perfusion of renal grafts using a novel acellular perfusate. Her technique focuses on the delivery of fibroblast growth factors during 24 hr ex situ perfusion at 32°C with the goal to trigger cellular pathways that induce cellular recovery after prolonged warm ischemia injury. 16, 17 This group focused on immunomodulation of vascular endothelium during the warm ex situ perfusion, limited by the need of a oxygen carrier agent in the perfusate with approval for human use. Snoeijs et al. reported the use of porcine renal grafts after 0, 30, and 45 min of WIT followed by cold machine perfusion (4°C) for 24 hr with follow-up for 10 days. Their results were primarily to describe the surgical methods for autologous renal transplant in pigs. 18 Their postoperative results of serum creatinine and bUn are similar to the ones observed in our studies. both values peaked to a maximum level on postoperative days 2-3, with a return to normal values on postoperative day 10. because of the UCUCA protocol approved by our institution, and to minimize animal suffering, we selected to stop the experiment and kill animals with serum creatinine more than 5 mg/dl.
We have presented some of this work at the international non-Heart beating Donor meeting. based partly on these presentations and discussion, Reznik of St Petersburg initiated a clinical program of ECS and thrombolytics in uDCD in humans. He gave heparin soon after declaration of death and STK at the time of ECS. The abdominal aorta was occluded with a balloon, and the room temperature was maintained. His circuit included an open reservoir and was primed with Custodiol-HTK, Solu-medrol (Pfizer Inc, new york, ny), and perfluorocarbon as an oxygen carrier. Dr. Reznik reported the application of this protocol in 22 human cadaveric donors with an average WIT of 61.4 min. The average venoarterial-ECS perfusion time before kidney procurement was 2.5 hr. [18] [19] [20] All 44 kidneys were transplanted. Delayed graft function (DGf) occurred in 70% requiring dialysis, but only one never functioned (primary graft failure).This study proves that kidneys can be conditioned to transplantable status using warm in situ ECS with thrombolytics in humans. longer perfusion, as in our laboratory study, may decrease the incidence of DGf.
Our study design has limitations compared with clinical uDCD. We induced cardiac arrest via apnea and did not attempt any resuscitative measures after cardiac death (maastricht type II), simulating out-of-hospital arrest. In future experiments, we will evaluate ECS after failed cardiopulmonary resuscitation and longer WIT. The animal model requires surgical incisions that are not performed in the clinical setting (access to monitoring lines in the neck and clamping of the abdominal aorta via a low thoracotomy); the extent of these incisions were associated with bleeding complications in two animals. We believe that in the clinical setting, the use of modified Seldinger's technique for cannulation with ultrasound guidance will limit the use of an open approach. 
Conclusion
In a porcine model of kidney transplantation, after 1 hr of WIT, the use of 4 hr of room temperature ECS resulted in immediate renal function, compared with no renal function in controls without ECS. The addition of thrombolytics and ECS with an automatic perfusion system were significant factors. Applied to clinical practice, extending the tolerable warm arrest time to 60 min could make uDCD feasible in any emergency room.
